| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/11/1994 | CA2148620A1 Indolylcarbamates as anti-inflammatory agents |
| 05/11/1994 | CA2148504A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 05/11/1994 | CA2148255A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders |
| 05/11/1994 | CA2147754A1 Compositions and methods for modifying the regulatory activity of tgf- .beta. |
| 05/11/1994 | CA2147598A1 Op-3-induced morphogenesis |
| 05/11/1994 | CA2147241A1 Inhibitors of farnesyl-protein transferase |
| 05/11/1994 | CA2147240A1 Inhibitors of farnesyl-protein transferase |
| 05/11/1994 | CA2146767A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 05/11/1994 | CA2146018A1 Dopamine receptor subtype ligands |
| 05/11/1994 | CA2145545A1 "sensitizing hiv-1 inhibitors" sensitize hiv infected individuals to "non-nucleoside hiv treatment drugs" |
| 05/11/1994 | CA2144161A1 Novel vitamin d analogues |
| 05/11/1994 | CA2136076A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
| 05/10/1994 | US5310959 Reacting 1-decyne with 1,4-dihalo-2-butyne using a strong base and then reacting with 5-hexynoic acid; reacting with an amine in the presense of carbonyldiimidazole to amidate |
| 05/10/1994 | US5310951 Benzopyran-2-propanoic acid derivatives; antiinflammatory agents |
| 05/10/1994 | US5310930 Cyclization of the carboximidate salt |
| 05/10/1994 | US5310927 Hypotensive agents; cognition activators; imidazolyl-2-aryl derivatives |
| 05/10/1994 | US5310763 Hydroxamino acid based collagenase inhibitors |
| 05/10/1994 | US5310743 1-acylpiperidine compounds |
| 05/10/1994 | US5310741 TAN-1251 compounds and their production from penicillium thomii |
| 05/10/1994 | US5310740 Renin inhibitors |
| 05/10/1994 | US5310737 Benzo-fused lactams that promote the release of growth hormone |
| 05/10/1994 | US5310551 Method for inhibiting pulmonary oxygen toxicity |
| 05/10/1994 | CA1329446C Peptides with laminin activity |
| 05/10/1994 | CA1329398C Compound active in cardiovascular therapy |
| 05/10/1994 | CA1329397C Hydroxamic acid based collagenase inhibitors |
| 05/10/1994 | CA1329392C Imidazole and triazole derivatives and antiviral and radiosensitizing agents comprising same |
| 05/10/1994 | CA1329390C Anti-inflammatory furanones |
| 05/04/1994 | EP0595659A2 Extracellular matrix receptor ligands that modulate leukocyte function |
| 05/04/1994 | EP0595610A1 Benzo-fused lactams |
| 05/04/1994 | EP0595557A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 05/04/1994 | EP0595365A1 Pharmaceutical composition for the treatment of underlying nonpharmacologically induced nervous system cholinergic deficit state comprising monoamine acridine derivatives |
| 05/04/1994 | EP0595183A1 Hydantoin derivatives, salts thereof and maillard reaction inhibitors comprising the same |
| 05/04/1994 | EP0595151A2 Imidazopyridine derivates as antagonists of angiotensin II |
| 05/04/1994 | EP0595133A2 Prodrugs, their preparation and use as medicaments |
| 05/04/1994 | EP0594999A1 Phospholipid derivatives containing higher elements of the fifth main group |
| 05/04/1994 | EP0594867A1 Agent for increasing somatostatin or for inhibiting decrease of somatostatin |
| 05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
| 05/04/1994 | EP0594667A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 05/04/1994 | EP0594659A1 Use of silicon compounds for preventing traumatic injuries |
| 05/04/1994 | EP0594656A1 4-amino-3-hydroxycarboxylic acid derivatives |
| 05/04/1994 | EP0594602A1 Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors |
| 05/04/1994 | EP0594588A1 Cycloalkyl-substituted glutaramide antihypertensive agents |
| 05/04/1994 | EP0594581A1 Production of glycosides, especially of steroidal glycosides |
| 05/04/1994 | EP0434832B1 D8- and D9-PROSTAGLANDINE DERIVATES, THEIR PROCESS OF PRODUCTION AND THEIR PHARMACEUTICAL USE |
| 05/04/1994 | EP0410006B1 Eye drops for healing wound of corneal epithelium |
| 05/04/1994 | EP0387314B1 Use of an agent active against retrovirus and products so produced |
| 05/04/1994 | CN1086221A Peptide compounds |
| 05/04/1994 | CN1086220A Androst-4-eno|4,5-b¨ pyrrole derivatives and process for their preparation |
| 05/04/1994 | CN1086214A Di-and triazinediones |
| 05/03/1994 | US5308889 Medical article for surgery |
| 05/03/1994 | US5308852 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| 05/03/1994 | US5308850 (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 05/03/1994 | US5308846 Vision defects, hypotensive agents |
| 05/03/1994 | US5308842 Ocular hypotensive agents; glaucoma |
| 05/03/1994 | US5308839 Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline |
| 05/03/1994 | CA2102137A1 Heterocyclic compounds |
| 05/03/1994 | CA1329204C Imidazo [4,5-.beta.] pyridine compounds and process for preparing same |
| 05/03/1994 | CA1329201C Thioformanidins, their preparation and use as drugs |
| 05/03/1994 | CA1329130C Ranitidine |
| 05/01/1994 | CA2109398A1 Extracellular matrix receptor ligands that modulate leukocyte function |
| 04/29/1994 | CA2107443A1 Benzo-fused lactams |
| 04/28/1994 | WO1994009130A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof |
| 04/28/1994 | WO1994009116A1 Cho cells expressing human endothelin receptors |
| 04/28/1994 | WO1994009037A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS |
| 04/28/1994 | WO1994009014A1 Pure enantiomers of phosphoric-acid esters as phospholipase-a2 inhibitors |
| 04/28/1994 | WO1994009010A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 04/28/1994 | WO1994008998A1 Imidazopyridine derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008996A1 Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 04/28/1994 | WO1994008995A1 Heterocyclic condensed benzoic acid derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008994A1 Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008993A1 Benzofuran derivatives as 5-ht1-like receptor antagonists |
| 04/28/1994 | WO1994008985A1 Benzopyranones, method of preparing them and their use |
| 04/28/1994 | WO1994008949A2 Metal-oxime chelates for use as radiopharmaceutical agents |
| 04/28/1994 | WO1994008609A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION |
| 04/28/1994 | WO1994008588A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 04/28/1994 | WO1994008580A1 Methods of combating pneumocystis carinii pneumonia and compounds useful therefor |
| 04/28/1994 | WO1994008574A1 Treatment of cachexia and inhibition of il-6 activity |
| 04/28/1994 | WO1994008573A1 Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
| 04/28/1994 | WO1994008560A1 Ranitidine chewable tablets |
| 04/28/1994 | WO1994005296A3 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 04/28/1994 | DE4228457A1 Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen Production of heterodimeric PDGF-AB using a bicistronic vector system in mammalian cells |
| 04/28/1994 | CA2147352A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives and use thereof |
| 04/28/1994 | CA2147180A1 Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function |
| 04/28/1994 | CA2147167A1 A new class of rptpases: their structural domains and ligands |
| 04/28/1994 | CA2147000A1 Ranitidine chewable tablets |
| 04/28/1994 | CA2146988A1 Treatment of cachexia and inhibition of il-6 activity |
| 04/28/1994 | CA2146930A1 Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists |
| 04/28/1994 | CA2146928A1 Imidazopyridine derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | CA2146923A1 Heterocyclic condensed benzoic acid derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | CA2146766A1 Polypeptides with a serotoninergic receptor activity (5ht2c) and uses therefor |
| 04/28/1994 | CA2146569A1 Benzofuran derivatives as 5-ht1-like receptor antagonists |
| 04/28/1994 | CA2146261A1 Sulfonamide derivatives of benzenefused, hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 04/27/1994 | EP0594257A1 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 04/27/1994 | EP0593976A1 Crystalline (R)-(-)-2-cycloheptyl-N-methylsulfonyl-4-(2-quinolinyl-methoxy)-phenyl-acetamide |
| 04/27/1994 | EP0593868A1 PEG-interferon conjugates |
| 04/27/1994 | EP0593794A1 Isolated mink growth hormone genes, novel recombinant DNA and methods for producing mink growth hormone |
| 04/27/1994 | EP0593595A1 Derivatives of inositol, preparations containing them and their use |
| 04/27/1994 | EP0593464A1 BENZOIC ACID DERIVATIVES and their use as LTB4 inhibitors |
| 04/27/1994 | EP0593457A1 Antimicrobial quinolone thioureas |
| 04/27/1994 | EP0505565B1 Quinoline derivatives, their production and use |